Mutual Funds

Mirae Asset Healthcare Fund Direct Growth

Mirae Asset Mutual FundThematicVery High Risk
₹50.2-0.50 (-0.99%)

NAV as on 2026-07-17 · Equity · Thematic

AUM

₹3,253 Cr

1Y Return

+13.3%

3Y CAGR

+24.6%

5Y CAGR

+15.6%

Expense

0.44%

Risk

Very High

Mirae Asset Healthcare Fund Direct Growth
₹50.2-0.99%

1Y Return

+13.3%

3Y CAGR

+24.6%

5Y CAGR

+15.6%

Since Inception

+22.1%

AI Fund Analysis

Get AI-powered verdict, strengths, risks, and SIP recommendations for this fund.

NAV History

Drag or scroll the chart to pan through history

52-Week NAV Range

₹40.46
₹50.75

95% from 52W low

Fund Information

ThematicEquitySince 03-07-2018

Fund House

Mirae Asset Mutual Fund

Category

Equity - Thematic

Min SIP

₹500

Min Lumpsum

₹5,000

Portfolio Composition

Asset Allocation

Equity99.8%
Cash0.2%
Other0.0%

Market Cap Split

Large Cap28.2%
Mid Cap45.3%
Small Cap26.9%

Top Holdings

37 stocks
Weight1M Change
1

Sun Pharmaceuticals Industries Ltd

Healthcare

12.20%-0.8%
2

Divi's Laboratories Ltd

Healthcare

7.93%+1.4%
3

Glenmark Pharmaceuticals Ltd

Healthcare

6.94%-2.8%
4

J.B. Chemicals & Pharmaceuticals Ltd

Healthcare

6.88%0.0%
5

Apollo Hospitals Enterprise Ltd

Healthcare

6.15%-1.5%
6

Lupin Ltd

Healthcare

5.06%-5.3%
7

Aurobindo Pharma Ltd

Healthcare

4.32%0.0%
8

Dr Reddy's Laboratories Ltd

Healthcare

4.31%0.0%
9

Fortis Healthcare Ltd

Healthcare

3.73%0.0%
10

Laurus Labs Ltd

Healthcare

3.56%+5.0%

Sector Allocation

Weight1M Change
Healthcare
99.1%-51%
Basic Materials
0.8%0%

Fundamentals

P/E Ratio

41.88

Cat avg: 42.12

P/B Ratio

5.89

Cat avg: 6.03

Dividend Yield

0.53%

Cat avg: 0.61%

Price/Sale

6.15

Price/Cash Flow

30.84

Risk Metrics (3Y)

Sharpe Ratio

1.07

Cat avg: 0.98

Sortino Ratio

1.95

Cat avg: 1.71

Beta

0.97

Cat avg: 0.95

Std Deviation

16.43%

Cat avg: 16.29%

Peer Comparison

FundAUM (Cr)Exp %1Y3Y5Y
Mirae Asset Healthcare Dir Gr3,2530.44+13.3%+24.6%+15.6%
Nippon India Pharma Dir Gr9,0440.79+7.5%+20.8%+13.4%
ICICI Pru Pharma Healthcare Diag Dir Gr6,6250.86+7.3%+25.6%+16.5%
SBI Healthcare Opportunities Dir Gr4,9981.03+14.8%+24.7%+17.4%
DSP Healthcare Fund Dir Gr3,5140.51+10.1%+23.0%+16.1%
HDFC Pharma and Healthcare Dir Gr2,6111.08+19.3%--
Tata India Pharma & Healthcare Dir Gr1,4550.67+8.2%+22.5%+14.8%
UTI Healthcare Dir Gr1,3081.31+12.7%+26.4%+15.4%
Aditya BSL Pharma & Hlthcare Dir Gr1,0110.82+14.9%+23.6%+14.6%
WhiteOak Capital Phrm and Hlthcr Dir Gr7410.60+17.6%--

What If I Had Invested?

NAV history not available for this range

Key Metrics

AUM₹3,253 Cr
Expense Ratio0.44%
Volatility (3Y)16.4%
Sharpe Ratio1.07
Sortino Ratio1.95
Beta0.97
Min SIP₹500
Min Lumpsum₹5,000
Holdings31

Risk-o-Meter

Low

Moderate

High

Very High

Rated as Very High risk

Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. NAV data sourced from AMFI. This is not SEBI-registered investment advice.